Healthscripts of america tulsa

2019-12-08 06:04

100 deals per day. Get access to the most exhaustive worldwide funding watch on the web! Comprehensive funding information. Know about who invested in a company, which sites covered the event, the funding history, etc.Address: 2448 E. 81ST STREET SUITE 5900 TULSA Phone number: Latest news HealthScripts of America Oklahoma City, LLC raised 200, 000 from 20 investors on. healthscripts of america tulsa

Healthscripts Of America Tulsa Llc, a enterprise based in Tulsa, United States, is a Medical devices and equipmentspecialized company. Please note that

Healthscripts of america tulsa free

Healthscripts of America Tulsa, LLC Overview This profile for Healthscripts of America Tulsa, LLC is located in Tulsa, OK. There are no officers listed for this company.

Get directions, reviews and information for Healthscripts of America in Bellaire, TX. Healthscripts of America 6565 West Loop S Bellaire TX. Reviews (713). Menu& Reservations Make Reservations. Order Online Tickets Tickets See Availability Directions

HEALTHSCRIPTS OF AMERICA OKLAHOMA CITY, LLC in OKLAHOMA CITY, OK. Profile from the NPI Registry.

Healthscripts Of America Tulsa, LLC is an Oklahoma Domestic LimitedLiability Company filed on December 11, 2012. The company's filing status is listed as

HealthScripts of America Tulsa, LLC raised 150, 000 in total. Directors and Executives of HealthScripts of America Tulsa, LLC. Key People in HealthScripts of America Tulsa, LLC:

HealthScripts of America Tulsa, LLC company research& investing information. Find executives and the latest company news.

View HealthScripts of America Tulsa, LLC Board of Directors profiles, including company insiders and other company Board Members.

Rating: 4.61 / Views: 579

In partnership with the worlds leading healthcare companies, HealthScripts provides peer reviewed educational opportunities, practitioner tools and patient access resources exclusively for Nurse Practitioners& Physician Assistants (NPs& PAs) interested in expanding care to patients.

2019 (c)
welrete
|